About Matinas BioPharma Holdings Inc
- Industry: Biotechnology
- Exchange: NYSE MKT LLC
- Country: US
- Website: https://www.matinasbiopharma.com/
Frequently Asked Questions
What is the 52-week range for MTNB?
The 52-week high is $29.55 and the 52-week low is $2.26.
What is the P/E ratio for MTNB?
The P/E ratio data is currently unavailable.
What is the dividend yield for MTNB?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -137.45%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -479.27%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.78.
Analyst Recommendation Trends
Wall Street analyst consensus for MTNB over the last few months:
Latest MTNB News
Matinas BioPharma Board Approves 1-For-15 Reverse Stock Split Effective September 28, 2026
On June 23, 2025, at the 2025 annual meeting of stockholders of Matinas BioPharma Holdings, Inc. (the "Company"), the stockholders approved the authorization of the Board of Directors (the "Board"), in
GH Power Signs Multi-Year Hydrogen Offtake Agreement with Change Energy for Hamilton Facility Output
Agreement establishes GH Power’s first commercial hydrogen offtake and validates hydrogen production from the Company’s proprietary aluminum-water reactor platformToronto, Canada, Sept. 14, 2026 (GLOBE NEWSWIRE) -- GH Power Inc. (“GH Power” or the “Company”) (NYSE American: MTNB), a Canadian clean energy and critical materials technology company, today announced that it has entered into a multi-year hydrogen supply agreement (the “Agreement”) with Change Energy Engineering Inc. on behalf of its
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
BEDMINSTER, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on August 31, 2026, it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $2.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-10 | STERN ADAM K | +141,462 | $0.35 | $49,512 |
| 2026-07-10 | STERN ADAM K | +344,710 | $0.35 | $120,648 |
| 2026-07-10 | STERN ADAM K | -344,710 | $0.35 | $120,648 |
| 2026-07-10 | STERN ADAM K | +630,335 | $0.35 | $220,617 |
| 2026-07-10 | STERN ADAM K | -630,335 | $0.35 | $220,617 |
| 2026-07-10 | STERN ADAM K | +630,335 | $0.35 | $220,617 |
| 2026-07-10 | STERN ADAM K | +344,710 | $0.35 | $120,648 |
| 2026-06-10 | Sanitam Partners LLC | -4,798,636 | $0.6446 | $3,093,201 |
| 2026-06-10 | Sanitam Partners LLC | -1,406 | $0.586 | $824 |
| 2025-10-31 | STERN ADAM K | -92,100 | $0.6446 | $59,368 |
| 2025-10-31 | STERN ADAM K | +92,100 | $0.6446 | $59,368 |
| 2025-10-16 | STERN ADAM K | +265 | $0.586 | $155 |
| 2025-10-16 | STERN ADAM K | +800,000 | $0.6446 | $515,680 |